Literature DB >> 19475463

Ala54Thr polymorphism of fatty acid binding protein 2, role on insulin resistance and cardiovascular risk factors in presurgical morbid obesity patients.

D A de Luis1, M Gonzalez Sagrado, R Aller, O Izaola, R Conde, Enrique Romero.   

Abstract

BACKGROUND: A transition G to A at codon 54 of fatty acid binding protein 2 (FABP2) results in an amino acid substitution (ala 54 to Thr 54). This polymorphism was associated with insulin resistance in some populations.
OBJECTIVE: The aim of our study was to investigate the influence of Thr54 polymorphism in the FABP2 gene on obesity anthropometric parameters, cardiovascular risk factors, and adipocytokines in patients with presurgical morbid obesity.
DESIGN: A population of 55 morbid obese patients was enrolled. An indirect calorimetry, tetrapolar electrical bioimpedance, blood pressure, a serial assessment of nutritional intake with 3 days of written food records, and biochemical analysis (lipid profile, adipocytokines, insulin, C-reactive protein, and lipoprotein-a) were performed. The statistical analysis was performed for the combined Ala54/Thr54 and Thr54/Thr54 as a mutant-type group and wild-type group (Ala54/Ala54).
RESULTS: Twenty nine (52.7%) had the genotype Ala54/Ala54 (wild-type group) and 26 (47.3%) patients had the genotype Ala54/Thr54 (24 patients, 43.7%) or Thr54/Thr54 (two patients, 3.6%; mutant-type group). Insulin (22.4 +/- 16.8 vs. 26.1 +/- 17.1 mg/dl; p = 0.04) and homeostasis model assessment (6.1 +/- 2.1 vs. 6.7 +/- 4.5; p = 0.04) levels were higher in mutant-type group than wild-type group. In mutant-type group, leptin levels (134.8 +/- 83 vs. 206.5 +/- 76 ng/ml; p = 0.03) were higher than wild-type group. Moreover, adiponectin levels (80.9 +/- 39.6 vs. 23.9 +/- 13.8 ng/ml; p = 0.02) were higher in wild-type group than mutant-type group.
CONCLUSION: The novel finding of this study is the association of Thr54 allele with insulin resistance, leptin, and adiponectin levels in morbidly obese patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19475463     DOI: 10.1007/s11695-009-9859-x

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  34 in total

1.  Validation of a kinetic model for the reactions in RIA.

Authors:  Maria J Duart Duart; Consuelo Olivas Arroyo; José Luis Moreno Frígols
Journal:  Clin Chem Lab Med       Date:  2002-11       Impact factor: 3.694

2.  Variants in the human intestinal fatty acid binding protein 2 gene in obese subjects.

Authors:  R Sipiläinen; M Uusitupa; S Heikkinen; A Rissanen; M Laakso
Journal:  J Clin Endocrinol Metab       Date:  1997-08       Impact factor: 5.958

Review 3.  Cellular and molecular aspects of fat metabolism in the small intestine.

Authors:  P Besnard; I Niot; A Bernard; H Carlier
Journal:  Proc Nutr Soc       Date:  1996-03       Impact factor: 6.297

Review 4.  Obesity.

Authors:  M Rosenbaum; R L Leibel; J Hirsch
Journal:  N Engl J Med       Date:  1997-08-07       Impact factor: 91.245

5.  Codon 54 polymorphism of the fatty acid binding protein 2 gene is associated with increased fat oxidation and hyperinsulinemia, but not with intestinal fatty acid absorption in Korean men.

Authors:  C H Kim; S K Yun; D W Byun; M H Yoo; K U Lee; K I Suh
Journal:  Metabolism       Date:  2001-04       Impact factor: 8.694

6.  Influence of ALA54THR polymorphism of fatty acid-binding protein 2 on obesity and cardiovascular risk factors.

Authors:  D A de Luis; M G Sagrado; R Aller; O Izaola; R Conde
Journal:  Horm Metab Res       Date:  2007-11       Impact factor: 2.936

7.  Biliopancreatic diversion.

Authors:  N Scopinaro; G F Adami; G M Marinari; E Gianetta; E Traverso; D Friedman; G Camerini; G Baschieri; A Simonelli
Journal:  World J Surg       Date:  1998-09       Impact factor: 3.352

8.  Influence of Ala54Thr polymorphism of fatty acid-binding protein-2 on clinical results of biliopancreatic diversion.

Authors:  Daniel A de Luis; Manuel González Sagrado; Olatz Izaola; Maria Concepcion Terroba; Luis Cuellar; Rosa Conde; Tomas Martin
Journal:  Nutrition       Date:  2008-02-15       Impact factor: 4.008

9.  Obesity, Type II diabetes and the Ala54Thr polymorphism of fatty acid binding protein 2 in the Tongan population.

Authors:  Natalia L Duarte; Stephen Colagiuri; Taniela Palu; Xing Li Wang; David E L Wilcken
Journal:  Mol Genet Metab       Date:  2003-07       Impact factor: 4.797

10.  Linkage of chromosomal markers on 4q with a putative gene determining maximal insulin action in Pima Indians.

Authors:  M Prochazka; S Lillioja; J F Tait; W C Knowler; D M Mott; M Spraul; P H Bennett; C Bogardus
Journal:  Diabetes       Date:  1993-04       Impact factor: 9.461

View more
  6 in total

Review 1.  Liver fatty acid-binding protein and obesity.

Authors:  Barbara P Atshaves; Gregory G Martin; Heather A Hostetler; Avery L McIntosh; Ann B Kier; Friedhelm Schroeder
Journal:  J Nutr Biochem       Date:  2010-11       Impact factor: 6.048

2.  A population-specific correlation between ADIPOQ rs2241766 and rs 1501299 and colorectal cancer risk: a meta-analysis for debate.

Authors:  Lin Ye; Guobin Wang; Yong Tang; Jie Bai
Journal:  Int J Clin Oncol       Date:  2016-10-04       Impact factor: 3.402

Review 3.  The roles of personalized nutrition in obesity and diabetes management: a review.

Authors:  Reihaneh Zeinalian; Shonaz Ahmadikhatir; Ensieh Nasli Esfahani; Nazli Namazi; Bagher Larijani
Journal:  J Diabetes Metab Disord       Date:  2022-04-04

4.  Fatty acid-binding protein 2 Ala54Thr genotype is associated with insulin resistance and leptin levels changes after a high monounsaturated fat diet in obese non-diabetic patients.

Authors:  D A de Luis; R Aller; O Izaola; M Gonzalez Sagrado; R Conde
Journal:  J Endocrinol Invest       Date:  2013-06       Impact factor: 4.256

5.  Effects Ala54Thr polymorphism of FABP2 on obesity index and biochemical variable in response to a aerobic exercise training.

Authors:  Tae Kyung Han
Journal:  J Exerc Nutrition Biochem       Date:  2013-12-09

6.  Analysis of hepatic transcriptome demonstrates altered lipid metabolism following Lactobacillus johnsonii BS15 prevention in chickens with subclinical necrotic enteritis.

Authors:  Xiaodan Qing; Dong Zeng; Hesong Wang; Xueqin Ni; Jing Lai; Lei Liu; Abdul Khalique; Kangcheng Pan; Bo Jing
Journal:  Lipids Health Dis       Date:  2018-04-20       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.